Summary: Clinical assays for factor XII determination are based on measurements of coagulation time in a mul-tifactorial assay requiring the availability of factor XII-deficient plasma, and the determination is affected by the presence of heparin. Another way of determining the amount of functionally active factor XII in plasma is to measure the amidolytic activity of factor XIIa in a chro-mogenic assay. We describe such an assay, which in con-trast to previously described chromogenic assays, is in-dependent of the presence of prekallikrein. To prevent kallikrein from interfering with the assay, soy bean trypsin inhibitor was added to the plasma. Factor XII was autoactivated by addition of ZnCl2 and sulfatide. Sul-fatide could be exchanged ...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
is a zymogen that is transformed into an active transglu-taminase by thrombin and Ca21. FXIII plays ...
When blood is exposed to variety of artificial surfaces and biologic substances, the plasma proteins...
Summary: A chromogenic assay for the determination of factor XII using the chromogenic substrate Chr...
Studies of the inactivation of factor XIIa by plasma protease inhibitors in purified systems and in ...
The activation of Factor IX by partially purified Factor XI " was followed by active site titra...
Abstract. To define the factors responsible for the inactivation ofthe active fragment derived from ...
j for the determination of factor XIII facilitates the diagnosis of factor XIII deficiency. In spite...
Blood biocompatibility of medical devices is in many ways dependent on surface characteristics and b...
Until recently, the role of factor XII (FXII) in hemostasis was not considered to be important since...
To define the factors responsible for the inactivation of the active fragment derived from Factor XI...
Abstract. A chromogenic factor IX assay is developed which requires only two time-dependent steps. D...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
It is well known that on artificial surfaces, binding and autoactivation of factor XII (FXII) is the...
Activated factor XII (FXIIa), the initiator of the contact activation system, has been shown to acti...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
is a zymogen that is transformed into an active transglu-taminase by thrombin and Ca21. FXIII plays ...
When blood is exposed to variety of artificial surfaces and biologic substances, the plasma proteins...
Summary: A chromogenic assay for the determination of factor XII using the chromogenic substrate Chr...
Studies of the inactivation of factor XIIa by plasma protease inhibitors in purified systems and in ...
The activation of Factor IX by partially purified Factor XI " was followed by active site titra...
Abstract. To define the factors responsible for the inactivation ofthe active fragment derived from ...
j for the determination of factor XIII facilitates the diagnosis of factor XIII deficiency. In spite...
Blood biocompatibility of medical devices is in many ways dependent on surface characteristics and b...
Until recently, the role of factor XII (FXII) in hemostasis was not considered to be important since...
To define the factors responsible for the inactivation of the active fragment derived from Factor XI...
Abstract. A chromogenic factor IX assay is developed which requires only two time-dependent steps. D...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
It is well known that on artificial surfaces, binding and autoactivation of factor XII (FXII) is the...
Activated factor XII (FXIIa), the initiator of the contact activation system, has been shown to acti...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
is a zymogen that is transformed into an active transglu-taminase by thrombin and Ca21. FXIII plays ...
When blood is exposed to variety of artificial surfaces and biologic substances, the plasma proteins...